JG
LRMR icon

Jain Global’s Larimar Therapeutics LRMR Stock Holding History

Jain Global’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.4K Buy
+13,566
New +$53.9K ﹤0.01% 1685
2025
Q2 		– Sell
-16,729
Closed -$36K – 1442
2025
Q1 		$36K Sell
16,729
-15,058
-47% -$47.6K ﹤0.01% 1024
2024
Q4 		$123K Buy
+31,787
New +$210K ﹤0.01% 682

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Jain Global's LRMR Position: Q2 2026 in Review

Jain Global opened a new position in Larimar Therapeutics (LRMR) in Q2 2026: 13,566 shares worth $41.4K. The stake represents ﹤0.01% of the portfolio and ranks #1685 among its holdings. This is a return to the name: Jain Global previously reported a position in LRMR as recently as Q1 2025.

Jain Global first reported a position in LRMR in Q4 2024 and has held it in 3 quarters since. The position peaked at $123K in Q4 2024. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Jain Global held 13,566 shares of Larimar Therapeutics worth $41.4K as of Q2 2026.
  • Larimar Therapeutics was a new Jain Global position in Q2 2026.
  • Larimar Therapeutics made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1685 holding.
  • Jain Global first reported a position in Larimar Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • Jain Global's Larimar Therapeutics position peaked at $123K in Q4 2024.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.